A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website July 9, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
Pirfenidone tablets with an active pharmaceutical ingredient made in Italy but sent for final processing in India is still a product of Italy for government procurement purposes, CBP said in a final determination released July 10. As the agency has said in a multitude of prior rulings, it found processing in a third country of an API into measured doses isn’t a substantial transformation if it doesn’t change the medicinal use of the API. Italy is a country designated as allowed for U.S. government procurement, while India isn’t, CBP noted.
In a social media posting the evening of July 9, President Donald Trump wrote, "I am announcing a 50% TARIFF on Copper effective August 1, 2025, after receiving a robust NATIONAL SECURITY ASSESSMENT."
Canada will face a 35% tariff on Aug. 1, based on a letter posted by President Donald Trump on social media late July 10. “Goods transshipped to evade this higher Tariff will be subject to that higher Tariff,” the letter said.
The Brazilian president hit back at President Donald Trump via X late July 9, after Trump said Brazilian goods should face 50% tariffs over the country's censorship of X and other American platforms, and partly because of the trial of former Brazilian president Jair Bolsonaro for an attempt to stay in power when the current president won election.
The head of the trade committee in the EU parliament said one of the sticking points in the negotiations with the U.S. is whether 50% tariffs on steel and 25% tariffs on cars and car parts continue to be collected as the two parties move from an agreement in principle to a detailed agreement.
The International Trade Commission published notices in the July 9 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission seeks comments by July 18 on a Section 337 complaint alleging that imports of wearable electroencephalogram devices infringe patents held by Ceribell Inc., it said in a notice to be published July 10. According to the complaint, Ceribell is seeking a limited exclusion order and cease and desist orders against Natus Medical Inc. and Excel-Tech Ltd. (acquired by Natus and now a Natus subsidiary) to bar from entry "certain wearable electroencephalogram devices and systems and components thereof" that violate its patents. Ceribell described its products as "a first-of-its-kind technology that integrates reliable highly portable hardware with proprietary AI-powered algorithms to deliver precise seizure detection and assessment in minutes rather than hours or days."
The International Trade Commission began a Section 337 investigation on allegations that 13 primarily Chinese companies are importing and selling electronic eyewear products that infringe patents held by IngenioSpec, the ITC said in a July 8 fact sheet (ITC Inv. No. 337-TA-1455). IngenioSpec filed the complaint in June and is seeking a limited exclusion order and cease and desist orders against the respondents to bar from entry "certain electronic eyewear products, components thereof, and related charging apparatuses" that violate the complainants' patents (see 2506120032).
The Commerce Department issued its final affirmative determinations in the antidumping duty and countervailing duty investigations on imports of tungsten shot from China, it said in a fact sheet issued July 8. Commerce set AD rates at 201.32% and CVD rates ranging from 55.64% to 292.84% for Chinese exporters, the agency said. These rates will take effect upon publication in the Federal Register of these final determinations, which should occur in the coming days.